Cara Therapeutics (NASDAQ:CARA) Coverage Initiated by Analysts at StockNews.com
StockNews.com started coverage on shares of Cara Therapeutics (NASDAQ:CARA – Free Report) in a research note published on Saturday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Cara Therapeutics Stock Down 4.3 % Cara Therapeutics stock opened at $5.15 on Friday. Cara Therapeutics has a twelve month low of $2.71 and a […]
StockNews.com started coverage on shares of Cara Therapeutics (NASDAQ:CARA – Free Report) in a research note published on Saturday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Cara Therapeutics Stock Down 4.3 % Cara Therapeutics stock opened at $5.15 on Friday. Cara Therapeutics has a twelve month low of $2.71 and a […]
